Rhenman & Partners Asset Management AB Takes $319,000 Position in Pulmonx Co. (NASDAQ:LUNG)
Rhenman & Partners Asset Management AB acquired a new stake in shares of Pulmonx Co. (NASDAQ:LUNG – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 25,000 shares of the company’s stock, valued at approximately $319,000. Rhenman […]
More Stories
Wedbush Trims IGM Biosciences (NASDAQ:IGMS) Target Price to $22.00
IGM Biosciences (NASDAQ:IGMS – Free Report) had its price target trimmed by Wedbush from $25.00 to $22.00 in a research...
Oppenheimer Increases Onto Innovation (NYSE:ONTO) Price Target to $275.00
Onto Innovation (NYSE:ONTO – Free Report) had its target price raised by Oppenheimer from $260.00 to $275.00 in a research...
Gritstone bio (NASDAQ:GRTS) Receives Neutral Rating from HC Wainwright
HC Wainwright restated their neutral rating on shares of Gritstone bio (NASDAQ:GRTS – Free Report) in a report published on...
Evercore ISI Raises KeyCorp (NYSE:KEY) Price Target to $20.00
KeyCorp (NYSE:KEY – Free Report) had its target price lifted by Evercore ISI from $18.50 to $20.00 in a report...
JPMorgan Chase & Co. Begins Coverage on Diamondback Energy (NASDAQ:FANG)
JPMorgan Chase & Co. began coverage on shares of Diamondback Energy (NASDAQ:FANG – Free Report) in a research note published...
Deutsche Bank Aktiengesellschaft Increases BWX Technologies (NYSE:BWXT) Price Target to $129.00
BWX Technologies (NYSE:BWXT – Get Free Report) had its target price raised by equities researchers at Deutsche Bank Aktiengesellschaft from...